These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 33473072)
1. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice. Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409 [TBL] [Abstract][Full Text] [Related]
3. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
4. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice. Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073 [TBL] [Abstract][Full Text] [Related]
5. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
6. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice. OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765 [TBL] [Abstract][Full Text] [Related]
7. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation. Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue. Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465 [TBL] [Abstract][Full Text] [Related]
9. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569 [TBL] [Abstract][Full Text] [Related]
10. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production. Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108 [TBL] [Abstract][Full Text] [Related]
11. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells. Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y Front Immunol; 2021; 12():635076. PubMed ID: 34025642 [TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis. Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695 [TBL] [Abstract][Full Text] [Related]
13. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789 [TBL] [Abstract][Full Text] [Related]
14. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses. Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437 [TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes. Yen LJ; Chen YC; Wang KC; Shih MC; Li CL; Yu SJ; Lu LY Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):128-137. PubMed ID: 38059657 [TBL] [Abstract][Full Text] [Related]
16. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice]. Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945 [TBL] [Abstract][Full Text] [Related]
17. Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways. Guo H; Li M; Liu H Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216231 [TBL] [Abstract][Full Text] [Related]
18. The Essential Oil Derived from Xu Y; Shi Y; Huang J; Gu H; Li C; Zhang L; Liu G; Zhou W; Du Z Molecules; 2022 May; 27(9):. PubMed ID: 35566346 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod. Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343 [TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]